Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Klotz Lh
Observed name:
L H Klotz
Institution:
University of Toronto
Observed institutions:
Memorial Sloan Kettering Cancer Center,
University of Toronto
OpenAlex ID:
A5083385360
Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
1998
·
J Tsihlias
, L R Kapusta
, et al.
·
PubMed
·
359
Surveillance programs for early stage non-seminomatous testicular cancer: a practice guideline.
2001
·
R Segal
, H Lukka
, et al.
·
PubMed
·
29
Why is the rate of testicular cancer increasing?
1999
·
L H Klotz
·
Europe PMC (PubMed Central)
·
14
Summary of intermittent endocrine therapy for advanced prostate cancer (by Laurence H. Klotz, MD, Harry W. Herr, MD, Michael J. Morse, MD, and Willet F. Whitmore, Jr, MD). 1986.
1997
·
L H Klotz
, P C Sogani
, et al.
·
PubMed
·
5
Randomized controlled trials in urologic oncology: a demographic analysis.
1994
·
L K Carr
, L H Klotz
·
PubMed
·
1
Modernity, urology, and September 11.
2001
·
L H Klotz
·
PubMed
Canada's Medicare gets mediocre marks.
2001
·
L H Klotz
·
PubMed
Prostate cancer screening.
2001
·
L H Klotz
·
PubMed
Allopathic versus 'holistic' medicine.
2000
·
L H Klotz
·
PubMed
Urology as practiced in the Canadian Health Care System.
2000
·
L H Klotz
·
PubMed
The role of nutrition in prostate cancer prevention.
2000
·
L H Klotz
·
PubMed
Caring for the "orphan" cancers.
1995
·
L H Klotz
·
PubMed
The BPH marketplace.
1995
·
L H Klotz
·
PubMed
Show more works
View as search
Works count:
13
Citation count:
408
H-index:
4
I10-index:
3
Year
Topic
Type